Multiple Sclerosis News Today

October 23, 2020October 24, 2020

VX-765 Therapy, Given Through Nose, Limits MS Progression in Early Study

The anti-inflammatory medication VX-765, which is delivered through the nose (intranasal), was found to limit disease progression in a preclinical model of multiple sclerosis (MS) by blocking a protein called ... Read more

October 23, 2020October 23, 2020

New Genetic Variants Found in African Americans of European Ancestry at Higher MS Risk

Multiple Sclerosis News Today

Two genetic variants have been identified by researchers within a genome region previously reported to drive a 1.44-times increased risk of multiple sclerosis (MS) in a group of African Americans ... Read more

October 22, 2020October 22, 2020

European Patent Given to IMP761, Antibody Aiming to Treat MS

Multiple Sclerosis News Today

The European Patent Office granted a patent for IMP761, Immutep‘s experimental antibody to be used in treating inflammatory and autoimmune conditions, including multiple sclerosis (MS). IMP761 targets a receptor found ... Read more

October 22, 2020October 22, 2020

Impact of Gut Microbiota in MS More Complex Than Thought, Study Shows

Multiple Sclerosis News Today

The presence of a particular gut bacterium widely used in probiotics, called Lactobacillus reuteri (L. reuteri), was sufficient to increase disease severity in a mouse model of multiple sclerosis (MS), ... Read more

October 21, 2020October 22, 2020

NanoStilbene Better Than Copaxone at Reducing MS Symptoms in Mouse Model

COVID-19 News, Multiple Sclerosis News Today

The nutritional supplement NanoStilbene, developed by Therapeutic Solutions International, worked better to reduce neurological damage and disease symptoms in an animal model of multiple sclerosis (MS) than the market-leading MS ... Read more

October 21, 2020October 21, 2020

Immune Cells’ Ability to Clear Myelin Debris Is Potential Therapeutic Approach for MS, Mouse Study Shows

Multiple Sclerosis News Today

Oral administration of trehalose — a sugar molecule found in plants and fungi and reported to have neuroprotective effects — eased symptoms and halted disease progression in a mouse model ... Read more

October 20, 2020October 20, 2020

Aslan Pharmaceuticals to Develop Aslan003 for Autoimmune Conditions

COVID-19 News, Multiple Sclerosis News Today

Aslan Pharmaceuticals announced it will develop Aslan003, a potent and highly selective next-generation modulator of the immune system, as a potential therapy for autoimmune diseases such as multiple sclerosis (MS). ... Read more

October 20, 2020October 20, 2020

Majority of MS Patients in US Report Mistreatment by Caregivers in Survey

Multiple Sclerosis News Today

In a nationwide survey of caregiver abuse and neglect among Americans with advanced multiple sclerosis (MS), more than half of respondents reported some form of mistreatment, with psychological and financial abuse being ... Read more

October 19, 2020October 19, 2020

Eli Lilly Aquires Disarm, Will Develop SARM1 Program for Axonal Degeneration

Multiple Sclerosis News Today

Eli Lilly has reached an agreement to acquire Disarm Therapeutics, a biotechnology company developing a new class of disease-modifying treatments for patients with axonal degeneration, including those with multiple sclerosis ... Read more

October 19, 2020October 19, 2020

Variation in Given Gene May Raise Depression Risk Among MS Patients

Multiple Sclerosis News Today

A genetic variant may make depression more likely in certain people with multiple sclerosis (MS) than others, a genome-wide study in patients indicates. The study, “Depression in multiple sclerosis patients associated with risk ... Read more

October 16, 2020October 16, 2020

Helius to Survey MS Users of Emilyn App in US With Gait Problems for PoNS Device

Multiple Sclerosis News Today

Helius Medical Technologies partnered with Breakthrough Health on a project focused on understanding how people with multiple sclerosis (MS) in the U.S. evaluate the therapies at their disposal in terms of how well ... Read more

October 16, 2020October 16, 2020

Mayzent Approved for Active SPMS Patients in England and Wales

Multiple Sclerosis News Today

Mayzent (siponimod) has become the first oral medication to be approved for people with active secondary progressive multiple sclerosis (SPMS) in England and Wales. Following this decision by England’s National ... Read more

October 15, 2020October 15, 2020

New Immune Cells Therapy Found to Suppress MS Symptoms in EAE Mice

Multiple Sclerosis News Today

Scientists developed a new therapy for multiple sclerosis (MS) that prevents immune cells from exiting the lymph nodes and entering the spinal cord of mice with experimental autoimmune encephalomyelitis (EAE) ... Read more

October 15, 2020October 15, 2020

Mayzent Approved for Active Secondary Progressive MS in Scotland

Multiple Sclerosis News Today

The Scottish Medicines Consortium (SMC) has approved Mayzent (siponimod) for the treatment of active secondary progressive multiple sclerosis (SPMS) in Scotland. Mayzent, developed by Novartis, is a tablet taken once ... Read more

October 14, 2020October 14, 2020

Aubagio’s Long-term Benefits Not Influenced by Prior Treatments, Review Finds

Multiple Sclerosis News Today

Prior treatment with disease-modifying therapies (DMTs) does not affect the long-term benefits of Aubagio (teriflunomide) in treating relapsing forms of multiple sclerosis (MS), according to a review study. The study, ... Read more